Cognito Appoints Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer
Position
Chief Technology Officer
Company
Cognito Therapeutics
Rhode IslandBiotechnologyHealth CareMedicalTherapeuticsDescription
Cognito announces the appointment of Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer to enhance its leadership team. These executives bring extensive experience in commercialization, technology, and operations as the company enters a new growth phase.
Quick answer
Cognito Appoints Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer (November 13, 2026). Cognito Therapeutics is based in Rhode Island, United States.
- Who is the new Chief Technology Officer at Cognito Therapeutics?
- Cognito Therapeutics named Urvashi Tyagi Chief Technology Officer, announced November 13, 2026.
- What did Cognito Therapeutics announce on November 13, 2026?
- Cognito announces the appointment of Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer to enhance its leadership team. These executives bring extensive experience in commercialization, technology, and operations as the company enters a new growth phase.
- Where did Urvashi Tyagi work before joining Cognito Therapeutics?
- Urvashi Tyagi joins from Freespira.
- What does Cognito Therapeutics do?
- Cognito Therapeutics is a medical technology company focused on neurodegenerative diseases, particularly Alzheimer’s.
- Where is Cognito Therapeutics based?
- Cognito Therapeutics is based in Rhode Island, United States.
- Which similar companies made leadership changes around the same time?
- OncoNano Medicine (November 10, 2026), Immuneering (November 9, 2026), Nanoscope Therapeutics (November 5, 2026) and Arcutis (November 5, 2026) also announced leadership changes within 45 days of Cognito Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OncoNano Medicine Appoints Brett P. Giroir as Chief Executive Officer (November 10, 2026)
- Grant C. Bogle Appointed as Class III Director at Immuneering Corporation (November 9, 2026)
- Nanoscope Therapeutics Appoints Damon Daulerio as Executive Director of Regulatory Affairs (November 5, 2026)
- Arcutis names Robert Lisicki Executive Vice President, Chief Commercial Officer (November 5, 2026)
- Peter Anastasiou Appointed as President and CEO of Harmony Biosciences (October 30, 2026)
- United Theranostics Appoints Amber Woodward-Smith as Chief Financial Officer (October 29, 2026)
Who to call at Cognito Therapeutics, and when
A new leader at Cognito Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cognito Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cognito Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cognito Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cognito Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.